on 'Packaging'

201-220 of 220 < first | | next | last >
  • Drug Counterfeiting Worsening Globally, Study Says

    This article from PLoS Medicine (April 2005) notes that up to 15% of all sold drugs are fake. The authors suggest that the reluctance of drug companies and governments to publicize this problem, and the subsequent lack of public health warnings, is harming patients and the long-term interests of the legitimate pharmaceutical industry.

  • Merck, Lilly Recalls Test RFID During Pilot

    A study involving Merck, Novartis, Schering, and Solvay found that RFID and trace and track work very well-two real-life drug recalls during the test showed just how effective the technology can be.

  • Has Wal-Mart Gone Soft?

    In a recent talk, Wal-Mart’s manager of RFID strategies sounded upbeat about his firm’s progress in end-to-end RFID shipping. But the retail giant’s not as far along as people think, says ARC Advisory Group’s Steve Banker.

  • Product Safety Risk Still Overlooked

    Government and industry have failed to confront this white elephant jointly. Concerted efforts, focused on risk, will be essential, asserts Carl Nielsen, FDA's former director of Import Operations and Policy, in this exclusive commentary.

  • It's Time for Open RFID

    The software industry had Linux. What will RFID users have to open up their systems? It's time to put enabling technology in the hands of the masses, says RFID Alliance Lab's Daniel Deavours.

  • Decoding FDA’s Bar Code Rule

    What packaging levels does the rule apply to? Should different coding be used for product and packaging? Bert Moore of AIM Global clears up the confusion.

  • Kaiser Poll Shows Public Distrust of Drug Makers

    The Kaiser Family Foundation recently polled 1,200 people regarding their views on drugs and the pharmaceutical industry, and the data revealed a fair amount of negativity toward drug manufacturers.

  • Bayer Warms Up to Cold Chain Supply

    Careful validation and quality assurance work, and close collaboration with vendors, was a “win-win” for all who helped develop Bayer Biological Products’ cold chain solutions.

  • Pfizer Goes On the Offensive

    Even before Peter Rost testified in favor of reimportation before a Senate committee, Pfizer SVP Chuck Hardwick had fired off this letter to Senate Committee Chairman Enzi, arguing that reimportation endangers the U.S. drug supply and the public.

  • How Pharma Can Find RFID's ROI

    Before they can embrace RFID and integrate it into their enterprise IT systems, pharmaceutical manufacturers must grapple with several key issues, including how to justify the ROI. In this exclusive interview, SAP's Jim Sabogal discusses problems firms are having with RFID, and strategies that SAP has in store.

  • Isotope Analysis Expands Its Forensic Niche

    Remember isotopes from Chemistry 101? As used in Stable Isotope Analysis, they offer a surefire way to authenticate APIs and products without additives. John P. Jasper, who helped pioneer the technology, discusses what it can do and where it's heading.

  • Pedigree Tags Need HF; FDA Agrees

    Pedigree RFID tags can never take off unless HF (13.56 MHz) becomes the norm; FDA appears to realize this, and is leaning toward HF at the unit level. Bert Moore of AIM Global discusses this situation.

  • Security: A Four-Step Approach

    There is no "silver bullet" for protecting the pharmaceutical supply chain. In this article, Susanne Hasselman, director of Axess Technologies, outlines a four-step strategy to improve brand protection.

  • Why Pharma's Anti-Tampering Strategies Don't Work

    "We've never seen what we would consider effective tamper-detection for a drug product," says Dr. Roger Johnston, head of the Vulnerability Assessment Team as Los Alamos National Laboratories. In this exclusive interview, Johnston gives us the ten top failings of anti-tampering efforts, and solutions for improvement. Also, click the "Download Now" button at the end of the article to obtain Johnston's PowerPoint presentation on improving tamper detection systems.

  • RFID Integration: Trying to Connect

    Middleware offers a way to integrate RFID, and the copious data it generates, with pharmaceutical manufacturers' current processes and systems.

    Doug Bartholomew, Contributing Editor
201-220 of 220 < first | | next | last >